NCT00442637View on ClinicalTrials.gov

Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma

PHASE3UnknownINTERVENTIONAL
Enrollment

635

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

capecitabine + bevacizumab

Ca 1250 mg/m2 daily orally continuously, B 7.5 mg/kg i.v. q 3 w

OTHER

observation

observation after induction treatment

Trial Locations (1)

Unknown

University Medical Center Nijmegen, Nijmegen

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Koningin Wilhelmina Fonds

OTHER

collaborator

Sanofi

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

lead

Dutch Colorectal Cancer Group

OTHER